| Literature DB >> 788731 |
Abstract
1. A clinical trial of the effects of indomethacin (200 mg daily) failed to show any objective evidence of improvement in six patients. 2. The same dose failed to inhibit exercise and antigen challenge induced bronchoconstriction, and this was considered to be evidence against the hypothesis that prostaglandins act as chemical mediatros in the pathogenesis of asthma.Entities:
Mesh:
Substances:
Year: 1975 PMID: 788731 PMCID: PMC1402590 DOI: 10.1111/j.1365-2125.1975.tb02775.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335